MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

Transcatheter Aortic Valve Replacement (TAVR) Transscatheter aortic valve replacement is a novel way to replace a diseased aortic valve without a median sternotomy. The first human TAVR was ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

New analysis from the EARLY TAVR trial showed patients between the age of 65 and 70 years old derived the most benefits of a strategy of early intervention with transcatheter aortic valve ...

Yang noted that SAVR and TAVR on their own just put valves in without any change in annular structure. Surgeons often turn ...

The following is a summary of “Postinterventional surveillance at a dedicated valve unit is safe and reduces intensive care ...

Transcatheter Aortic Valve Replacement (TAVR) Versus Surgical Aortic Valve Replacement (SAVR) in Low-Risk Patients at 5 Years: An Updated Meta-Analysis of Randomized Controlled Trials. Presenter: ...

Aortic stenosis is a heart valve disease that some people don't realize they have. So what is it, how is it treated?

Frame design influences critical parameters such as radial strength, flexibility, fatigue resistance and conformability to ...

The U.K. National Health Service may or may not deploy transcatheter aortic valve replacement devices as widely as in the U.S., but the National Institute for Health and Care Excellence officially ...

Facility Director at SDM Narayana Heart Centre Shashikumar I. Pattanshetti said that the team’s expertise and patient-focused ...